Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1967 1
1968 2
1969 1
1971 2
1972 1
1973 2
1974 1
1975 19
1976 17
1977 15
1978 22
1979 20
1980 14
1981 22
1982 16
1983 21
1984 37
1985 35
1986 30
1987 21
1988 27
1989 25
1990 33
1991 41
1992 46
1993 35
1994 29
1995 37
1996 22
1997 27
1998 22
1999 22
2000 28
2001 27
2002 17
2003 25
2004 34
2005 27
2006 26
2007 30
2008 29
2009 25
2010 29
2011 34
2012 40
2013 29
2014 26
2015 33
2016 28
2017 26
2018 25
2019 28
2020 31
2021 33
2022 42
2023 30
2024 9

Text availability

Article attribute

Article type

Publication date

PubMed for id: 42149

1,289 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
Martakis K, Claassen J, Gascon-Bayari J, Goldschagg N, Hahn A, Hassan A, Hennig A, Jones S, Kay R, Lau H, Perlman S, Sharma R, Schneider S, Bremova-Ertl T. Martakis K, et al. Neurology. 2023 Mar 7;100(10):e1072-e1083. doi: 10.1212/WNL.0000000000201660. Epub 2022 Dec 1. Neurology. 2023. PMID: 36456200 Free PMC article. Clinical Trial.
[A case of GM1 gangliosidoses].
Liu LL, Li L. Liu LL, et al. Zhonghua Yan Ke Za Zhi. 2022 Oct 11;58(10):793-795. doi: 10.3760/cma.j.cn112142-20211013-00478. Zhonghua Yan Ke Za Zhi. 2022. PMID: 36220651 Chinese.
Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients.
Welford RWD, Farine H, Steiner M, Garzotti M, Dobrenis K, Sievers C, Strasser DS, Amraoui Y, Groenen PMA, Giugliani R, Mengel E. Welford RWD, et al. Mol Genet Metab Rep. 2022 Feb 1;30:100843. doi: 10.1016/j.ymgmr.2022.100843. eCollection 2022 Mar. Mol Genet Metab Rep. 2022. PMID: 35242574 Free PMC article.
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation.
Castejón-Vega B, Rubio A, Pérez-Pulido AJ, Quiles JL, Lane JD, Fernández-Domínguez B, Cachón-González MB, Martín-Ruiz C, Sanz A, Cox TM, Alcocer-Gómez E, Cordero MD. Castejón-Vega B, et al. Cells. 2021 Nov 11;10(11):3122. doi: 10.3390/cells10113122. Cells. 2021. PMID: 34831346 Free PMC article.
Chitotriosidase as a biomarker for gangliosidoses.
Kim S, Whitley CB, Jarnes JR. Kim S, et al. Mol Genet Metab Rep. 2021 Oct 1;29:100803. doi: 10.1016/j.ymgmr.2021.100803. eCollection 2021 Dec. Mol Genet Metab Rep. 2021. PMID: 34646735 Free PMC article.
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.
Fields T, Patterson M, Bremova-Ertl T, Belcher G, Billington I, Churchill GC, Davis W, Evans W, Flint S, Galione A, Granzer U, Greenfield J, Karl R, Kay R, Lewi D, Mathieson T, Meyer T, Pangonis D, Platt FM, Tsang L, Verburg C, Factor M, Strupp M. Fields T, et al. Trials. 2021 Jan 22;22(1):84. doi: 10.1186/s13063-020-05009-3. Trials. 2021. PMID: 33482890 Free PMC article.
1,289 results